These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24388359)

  • 1. The 5p12 breast cancer susceptibility locus affects MRPS30 expression in estrogen-receptor positive tumors.
    Quigley DA; Fiorito E; Nord S; Van Loo P; Alnæs GG; Fleischer T; Tost J; Moen Vollan HK; Tramm T; Overgaard J; Bukholm IR; Hurtado A; Balmain A; Børresen-Dale AL; Kristensen V
    Mol Oncol; 2014 Mar; 8(2):273-84. PubMed ID: 24388359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.
    Ghoussaini M; French JD; Michailidou K; Nord S; Beesley J; Canisus S; Hillman KM; Kaufmann S; Sivakumaran H; Moradi Marjaneh M; Lee JS; Dennis J; Bolla MK; Wang Q; Dicks E; Milne RL; Hopper JL; Southey MC; Schmidt MK; Broeks A; Muir K; Lophatananon A; Fasching PA; Beckmann MW; Fletcher O; Johnson N; Sawyer EJ; Tomlinson I; Burwinkel B; Marme F; Guénel P; Truong T; Bojesen SE; Flyger H; Benitez J; González-Neira A; Alonso MR; Pita G; Neuhausen SL; Anton-Culver H; Brenner H; Arndt V; Meindl A; Schmutzler RK; Brauch H; Hamann U; Tessier DC; Vincent D; Nevanlinna H; Khan S; Matsuo K; Ito H; Dörk T; Bogdanova NV; Lindblom A; Margolin S; Mannermaa A; Kosma VM; ; Wu AH; Van Den Berg D; Lambrechts D; Floris G; Chang-Claude J; Rudolph A; Radice P; Barile M; Couch FJ; Hallberg E; Giles GG; Haiman CA; Le Marchand L; Goldberg MS; Teo SH; Yip CH; Borresen-Dale AL; ; Zheng W; Cai Q; Winqvist R; Pylkäs K; Andrulis IL; Devilee P; Tollenaar RA; García-Closas M; Figueroa J; Hall P; Czene K; Brand JS; Darabi H; Eriksson M; Hooning MJ; Koppert LB; Li J; Shu XO; Zheng Y; Cox A; Cross SS; Shah M; Rhenius V; Choi JY; Kang D; Hartman M; Chia KS; Kabisch M; Torres D; Luccarini C; Conroy DM; Jakubowska A; Lubinski J; Sangrajrang S; Brennan P; Olswold C; Slager S; Shen CY; Hou MF; Swerdlow A; Schoemaker MJ; Simard J; Pharoah PD; Kristensen V; Chenevix-Trench G; Easton DF; Dunning AM; Edwards SL
    Am J Hum Genet; 2016 Oct; 99(4):903-911. PubMed ID: 27640304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comprehensive cis-eQTL Analysis Revealed Target Genes in Breast Cancer Susceptibility Loci Identified in Genome-wide Association Studies.
    Guo X; Lin W; Bao J; Cai Q; Pan X; Bai M; Yuan Y; Shi J; Sun Y; Han MR; Wang J; Liu Q; Wen W; Li B; Long J; Chen J; Zheng W
    Am J Hum Genet; 2018 May; 102(5):890-903. PubMed ID: 29727689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative Genomic Analysis Predicts Causative
    Zhang Y; Manjunath M; Zhang S; Chasman D; Roy S; Song JS
    Cancer Res; 2018 Apr; 78(7):1579-1591. PubMed ID: 29351903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic susceptibility loci for breast cancer by estrogen receptor status.
    Garcia-Closas M; Chanock S
    Clin Cancer Res; 2008 Dec; 14(24):8000-9. PubMed ID: 19088016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.
    Glubb DM; Maranian MJ; Michailidou K; Pooley KA; Meyer KB; Kar S; Carlebur S; O'Reilly M; Betts JA; Hillman KM; Kaufmann S; Beesley J; Canisius S; Hopper JL; Southey MC; Tsimiklis H; Apicella C; Schmidt MK; Broeks A; Hogervorst FB; van der Schoot CE; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Fasching PA; Ruebner M; Ekici AB; Beckmann MW; Peto J; dos-Santos-Silva I; Fletcher O; Johnson N; Pharoah PD; Bolla MK; Wang Q; Dennis J; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Burwinkel B; Marme F; Yang R; Surowy H; Guénel P; Truong T; Menegaux F; Sanchez M; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; González-Neira A; Benitez J; Zamora MP; Arias Perez JI; Anton-Culver H; Neuhausen SL; Brenner H; Dieffenbach AK; Arndt V; Stegmaier C; Meindl A; Schmutzler RK; Brauch H; Ko YD; Brüning T; ; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Matsuo K; Ito H; Iwata H; Tanaka H; Dörk T; Bogdanova NV; Helbig S; Lindblom A; Margolin S; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; ; Wu AH; Tseng CC; Van Den Berg D; Stram DO; Lambrechts D; Zhao H; Weltens C; van Limbergen E; Chang-Claude J; Flesch-Janys D; Rudolph A; Seibold P; Radice P; Peterlongo P; Barile M; Capra F; Couch FJ; Olson JE; Hallberg E; Vachon C; Giles GG; Milne RL; McLean C; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Simard J; Goldberg MS; Labrèche F; Dumont M; Teo SH; Yip CH; See MH; Cornes B; Cheng CY; Ikram MK; Kristensen V; ; Zheng W; Halverson SL; Shrubsole M; Long J; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Kauppila S; Andrulis IL; Knight JA; Glendon G; Tchatchou S; Devilee P; Tollenaar RA; Seynaeve C; Van Asperen CJ; García-Closas M; Figueroa J; Chanock SJ; Lissowska J; Czene K; Klevebring D; Darabi H; Eriksson M; Hooning MJ; Hollestelle A; Martens JW; Collée JM; Hall P; Li J; Humphreys K; Shu XO; Lu W; Gao YT; Cai H; Cox A; Cross SS; Reed MW; Blot W; Signorello LB; Cai Q; Shah M; Ghoussaini M; Kang D; Choi JY; Park SK; Noh DY; Hartman M; Miao H; Lim WY; Tang A; Hamann U; Torres D; Jakubowska A; Lubinski J; Jaworska K; Durda K; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Olswold C; Slager S; Toland AE; Yannoukakos D; Shen CY; Wu PE; Yu JC; Hou MF; Swerdlow A; Ashworth A; Orr N; Jones M; Pita G; Alonso MR; Álvarez N; Herrero D; Tessier DC; Vincent D; Bacot F; Luccarini C; Baynes C; Ahmed S; Healey CS; Brown MA; Ponder BA; Chenevix-Trench G; Thompson DJ; Edwards SL; Easton DF; Dunning AM; French JD
    Am J Hum Genet; 2015 Jan; 96(1):5-20. PubMed ID: 25529635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two promoters in expression of estrogen receptor messenger RNA in human breast cancer.
    Hayashi S; Imai K; Suga K; Kurihara T; Higashi Y; Nakachi K
    Carcinogenesis; 1997 Mar; 18(3):459-64. PubMed ID: 9067542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. eQTL Colocalization Analyses Identify NTN4 as a Candidate Breast Cancer Risk Gene.
    Beesley J; Sivakumaran H; Moradi Marjaneh M; Shi W; Hillman KM; Kaufmann S; Hussein N; Kar S; Lima LG; Ham S; Möller A; Chenevix-Trench G; Edwards SL; French JD
    Am J Hum Genet; 2020 Oct; 107(4):778-787. PubMed ID: 32871102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population.
    Chan M; Ji SM; Liaw CS; Yap YS; Law HY; Yoon CS; Wong CY; Yong WS; Wong NS; Ng R; Ong KW; Madhukumar P; Oey CL; Tan PH; Li HH; Ang P; Ho GH; Lee AS
    Breast Cancer Res Treat; 2012 Nov; 136(1):209-20. PubMed ID: 22965832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer.
    Stacey SN; Manolescu A; Sulem P; Thorlacius S; Gudjonsson SA; Jonsson GF; Jakobsdottir M; Bergthorsson JT; Gudmundsson J; Aben KK; Strobbe LJ; Swinkels DW; van Engelenburg KC; Henderson BE; Kolonel LN; Le Marchand L; Millastre E; Andres R; Saez B; Lambea J; Godino J; Polo E; Tres A; Picelli S; Rantala J; Margolin S; Jonsson T; Sigurdsson H; Jonsdottir T; Hrafnkelsson J; Johannsson J; Sveinsson T; Myrdal G; Grimsson HN; Sveinsdottir SG; Alexiusdottir K; Saemundsdottir J; Sigurdsson A; Kostic J; Gudmundsson L; Kristjansson K; Masson G; Fackenthal JD; Adebamowo C; Ogundiran T; Olopade OI; Haiman CA; Lindblom A; Mayordomo JI; Kiemeney LA; Gulcher JR; Rafnar T; Thorsteinsdottir U; Johannsson OT; Kong A; Stefansson K
    Nat Genet; 2008 Jun; 40(6):703-6. PubMed ID: 18438407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer risk associated with genotypic polymorphism of the genes involved in the estrogen-receptor-signaling pathway: a multigenic study on cancer susceptibility.
    Yu JC; Hsu HM; Chen ST; Hsu GC; Huang CS; Hou MF; Fu YP; Cheng TC; Wu PE; Shen CY
    J Biomed Sci; 2006 May; 13(3):419-32. PubMed ID: 16502042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative assessment of common genetic variants on chromosome 5p12 and hormone receptor status with breast cancer risk.
    Yu Y; Chen Z; Wang H; Zhang Y
    PLoS One; 2013; 8(8):e72154. PubMed ID: 23977236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.
    Mulligan AM; Couch FJ; Barrowdale D; Domchek SM; Eccles D; Nevanlinna H; Ramus SJ; Robson M; Sherman M; Spurdle AB; Wappenschmidt B; Lee A; McGuffog L; Healey S; Sinilnikova OM; Janavicius R; Hansen Tv; Nielsen FC; Ejlertsen B; Osorio A; Muñoz-Repeto I; Durán M; Godino J; Pertesi M; Benítez J; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Cattaneo E; Bonanni B; Viel A; Pasini B; Papi L; Ottini L; Savarese A; Bernard L; Radice P; Hamann U; Verheus M; Meijers-Heijboer HE; Wijnen J; Gómez García EB; Nelen MR; Kets CM; Seynaeve C; Tilanus-Linthorst MM; van der Luijt RB; van Os T; Rookus M; Frost D; Jones JL; Evans DG; Lalloo F; Eeles R; Izatt L; Adlard J; Davidson R; Cook J; Donaldson A; Dorkins H; Gregory H; Eason J; Houghton C; Barwell J; Side LE; McCann E; Murray A; Peock S; Godwin AK; Schmutzler RK; Rhiem K; Engel C; Meindl A; Ruehl I; Arnold N; Niederacher D; Sutter C; Deissler H; Gadzicki D; Kast K; Preisler-Adams S; Varon-Mateeva R; Schoenbuchner I; Fiebig B; Heinritz W; Schäfer D; Gevensleben H; Caux-Moncoutier V; Fassy-Colcombet M; Cornelis F; Mazoyer S; Léoné M; Boutry-Kryza N; Hardouin A; Berthet P; Muller D; Fricker JP; Mortemousque I; Pujol P; Coupier I; Lebrun M; Kientz C; Longy M; Sevenet N; Stoppa-Lyonnet D; Isaacs C; Caldes T; de la Hoya M; Heikkinen T; Aittomäki K; Blanco I; Lazaro C; Barkardottir RB; Soucy P; Dumont M; Simard J; Montagna M; Tognazzo S; D'Andrea E; Fox S; Yan M; Rebbeck T; Olopade O; Weitzel JN; Lynch HT; Ganz PA; Tomlinson GE; Wang X; Fredericksen Z; Pankratz VS; Lindor NM; Szabo C; Offit K; Sakr R; Gaudet M; Bhatia J; Kauff N; Singer CF; Tea MK; Gschwantler-Kaulich D; Fink-Retter A; Mai PL; Greene MH; Imyanitov E; O'Malley FP; Ozcelik H; Glendon G; Toland AE; Gerdes AM; Thomassen M; Kruse TA; Jensen UB; Skytte AB; Caligo MA; Soller M; Henriksson K; Wachenfeldt vA; Arver B; Stenmark-Askmalm M; Karlsson P; Ding YC; Neuhausen SL; Beattie M; Pharoah PD; Moysich KB; Nathanson KL; Karlan BY; Gross J; John EM; Daly MB; Buys SM; Southey MC; Hopper JL; Terry MB; Chung W; Miron AF; Goldgar D; Chenevix-Trench G; Easton DF; Andrulis IL; Antoniou AC; ; ; ; ; ; ; ;
    Breast Cancer Res; 2011; 13(6):R110. PubMed ID: 22053997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NDF induces expression of a novel 46 kD protein in estrogen receptor positive breast cancer cells.
    Kumar R; Mandal M; Ratzkin BJ; Liu N; Lipton A
    J Cell Biochem; 1996 Jul; 62(1):102-12. PubMed ID: 8836879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence.
    Fackler MJ; Umbricht CB; Williams D; Argani P; Cruz LA; Merino VF; Teo WW; Zhang Z; Huang P; Visvananthan K; Marks J; Ethier S; Gray JW; Wolff AC; Cope LM; Sukumar S
    Cancer Res; 2011 Oct; 71(19):6195-207. PubMed ID: 21825015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations.
    Fu YP; Edvardsen H; Kaushiva A; Arhancet JP; Howe TM; Kohaar I; Porter-Gill P; Shah A; Landmark-Høyvik H; Fosså SD; Ambs S; Naume B; Børresen-Dale AL; Kristensen VN; Prokunina-Olsson L
    Mol Cancer; 2010 May; 9():113. PubMed ID: 20482849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trans-ethnic predicted expression genome-wide association analysis identifies a gene for estrogen receptor-negative breast cancer.
    Gao G; Pierce BL; Olopade OI; Im HK; Huo D
    PLoS Genet; 2017 Sep; 13(9):e1006727. PubMed ID: 28957356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of three genetic determinants of susceptibility to estrogen-induced mammary cancer within the Emca8 locus on rat chromosome 5.
    Schaffer BS; Leland-Wavrin KM; Kurz SG; Colletti JA; Seiler NL; Warren CL; Shull JD
    Cancer Prev Res (Phila); 2013 Jan; 6(1):59-69. PubMed ID: 23151807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variants at IRX4 as prostate cancer expression quantitative trait loci.
    Xu X; Hussain WM; Vijai J; Offit K; Rubin MA; Demichelis F; Klein RJ
    Eur J Hum Genet; 2014 Apr; 22(4):558-63. PubMed ID: 24022300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen induces estrogen-related receptor alpha gene expression and chromatin structural changes in estrogen receptor (ER)-positive and ER-negative breast cancer cells.
    Hu P; Kinyamu HK; Wang L; Martin J; Archer TK; Teng C
    J Biol Chem; 2008 Mar; 283(11):6752-63. PubMed ID: 18174157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.